Ypso-Facto
keyboard_backspaceBack to Home
Contact
19 Avenue Foch
54000 Nancy
France
Customer Success Manager
About us
Ypso-Facto has been helping Pharmaceutical and Biopharmaceutical companies optimize their processes since 2014. Our proven methodology combines our/your expertise, well-targeted experiments, and predictive simulation to solve the biggest challenges in (bio)process development.
Business offer
Ypso-Facto is a company specializing in the development of bioprocesses, offering a unique combination of services relying on advanced software tools. This hybrid offering is designed to help our clients reduce their experimental effort by enhancing the performance of their processes. Our software suite consists of several specialized applications, from establishing a complete process diagram to detailed simulation of chromatographic processes, including a module focused on economic and environmental analysis. Thanks to a proven methodology, Ypso-Facto has been recognized internationally by several major players in biopharmaceutical production. This recognition underscores our commitment to excellence and innovation in the field of biotechnologies.
Activities
- Service
- CMC
- Cell Culture
- Bioreactor conditions
- Bioproduction
- Batches production type
- Mammalian
- Insect
- Yeast
- Bacterial
- Pilot Batches
- Tests
- Optimization
- Scale-Up process
- Process optimization & validation
- Volume
- Low volume (< 200 L)
- High volume (200 – 2000 L)
- Very high volume (> 2000 L)
- Commercial
- USP (Scale-Up)
- Cell expansion
- Inoculation
- Low volume containers to Bioreactors
- DSP (Recovery)
- Harvest
- Filtration
- Purification
- CMC/analytical quality assessment, quality control
- Cleaning
- Bioproduction engineering
- Cell Expansion
- Scale-Up
- Process optimization
- Purification/Extraction
- Filtration / microfiltration / ultrafiltration
- Centrifugation
- Chromatography
- Bioproduction modeling
- Metabolic / Kinetic modeling
- Control / command
- Global optimization
- Economic analyses
- Artificial Intelligence tools
- Bioproduction/CMC/Analytical Quality Assessment, Quality Control
- Bioproduction
- Scale-Up
- Cleaning
- CMC
- Cell Culture / Fermentation
- Bioreactor conditions (cell in suspension, adherent cell player)
- Bioproduction GMP
- Vaccine platform type
- Recombinant protein expression
- Synthetic Peptides or oligomers
- Virus-like particles (VLP) and nanoparticle-based carriers
- killed/inactivated virus
- Live attenuated virus
- Viral vector encoding target antigen
- DNA plasmid vaccine
- mRNA vaccine
- Lipid delivery vehicle
- Outer-membrane vesicles (OMV)
- Polysaccharides/ conjugated vaccines
- Other
- Pilot Batches scale
- Process development & optimization
- Scale-Up & Validation
- Comparability characterization protocol
- Manufacturing Volume
- Small volume (< 100 L) adjusted to phase I/II needs: specify volume
- Large volume (100 – 1000 L) adapted for phase III needs
- Final scale up volume (> 1000 L) and validation for manufacturing
- Commercial supply during life cycle management
- USP (Scale-Up)
- DSP (Recovery)
